The six-month study conducted in regions of Uganda where malaria is endemic included 400 mothers and their babies, ages 6 ...
Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for TNKase® (tenecteplase), a thrombolytic (clot-dissolving) agent, effective November ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback